Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C19H23NO4 |
Molecular Weight | 329.3902 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12OC3=C4C(C[C@H]5N(CC=C)CC[C@@]14[C@@]5(O)CC[C@@H]2O)=CC=C3O
InChI
InChIKey=HMWHERQFMBEHNG-AQQQZIQISA-N
InChI=1S/C19H23NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,13-14,17,21-23H,1,5-10H2/t13-,14+,17-,18-,19+/m0/s1
Molecular Formula | C19H23NO4 |
Molecular Weight | 329.3902 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11413242Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19061911 | https://www.ncbi.nlm.nih.gov/pubmed/15956992
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11413242
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/19061911 | https://www.ncbi.nlm.nih.gov/pubmed/15956992
6-alpha-Naloxol is active metabolite of naloxone. 6-alpha-Naloxol was shown to be neutral antagonist at the mu receptor in vitro, with no affect on cAMP levels or GTPitalic gammaS binding, regardless of morphine pretreatment. It elicits withdrawal behaviour and conditioned place aversion in morphine pretreated rodents.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19061911 | https://www.ncbi.nlm.nih.gov/pubmed/15956992
Curator's Comment: 6-alpha-Naloxol is CNS active in animals. No human data available.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL233 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11413242 |
0.63 nM [Ki] | ||
Target ID: CHEMBL236 Sources: https://www.ncbi.nlm.nih.gov/pubmed/11413242 |
2.1 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence. | 2001 Jun |
|
Constitutively active micro opioid receptors mediate the enhanced conditioned aversive effect of naloxone in morphine-dependent mice. | 2006 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15956992
rats: 0.05–100 mg/kg, s.c.
Route of Administration:
Other
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:49:59 GMT 2023
by
admin
on
Sat Dec 16 10:49:59 GMT 2023
|
Record UNII |
FLW43Q2H9L
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID20942579
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
5492271
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
Naloxol
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
m11769
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
300000013056
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
20410-95-1
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY | |||
|
FLW43Q2H9L
Created by
admin on Sat Dec 16 10:49:59 GMT 2023 , Edited by admin on Sat Dec 16 10:49:59 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE LESS ACTIVE |
Results also indicate that delay in onset of action of 6-alpha-naloxol at opioid receptors in the central nervous system may contribute significantly to its reduced potency relative to naloxone under certain morphine pretreatment conditions.
|
||
|
PARENT -> METABOLITE |
URINE
|